Literature DB >> 3628803

Relationship of morphology of ependymoma in children to prognosis.

L B Rorke.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3628803     DOI： 10.1159/000413674

Source DB:  PubMed          Journal:  Prog Exp Tumor Res        ISSN： 0079-6263


× No keyword cloud information.
  8 in total

1.  Adjunctive treatment for recurrent childhood ependymoma of the IV ventricle: chemotherapy with CDDP and MCNU.

Authors:  M Tamura; N Ono; H Kurihara; C Ohye; M Miyazaki
Journal:  Childs Nerv Syst       Date:  1990-06       Impact factor: 1.475

2.  A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma.

Authors:  D M Ho; C Y Hsu; T T Wong; H Chiang
Journal:  J Neurooncol       Date:  2001-08       Impact factor: 4.130

3.  Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma--a report of the Children's Cancer Group.

Authors:  W P Mason; S Goldman; A J Yates; J Boyett; H Li; J L Finlay
Journal:  J Neurooncol       Date:  1998-04       Impact factor: 4.130

4.  Intracranial ependymomas in children.

Authors:  S Undjian; M Marinov
Journal:  Childs Nerv Syst       Date:  1990-05       Impact factor: 1.475

5.  Histologic prognostic factors in ependymoma.

Authors:  D Schiffer; A Chiò; M T Giordana; A Migheli; L Palma; B Pollo; R Soffietti; A Tribolo
Journal:  Childs Nerv Syst       Date:  1991-08       Impact factor: 1.475

6.  Malignant hemispheric tumors in childhood.

Authors:  E Hoppe-Hirsch; J F Hirsch; A Lellouch-Tubiana; A Pierre-Kahn; C Sainte-Rose; D Renier
Journal:  Childs Nerv Syst       Date:  1993-06       Impact factor: 1.475

7.  Ependymomas: MIB-1 proliferation index and survival.

Authors:  A M Ritter; K R Hess; R E McLendon; L A Langford
Journal:  J Neurooncol       Date:  1998-10       Impact factor: 4.130

8.  Intracranial ependymoma in children: analysis of prognostic factors.

Authors:  J K Chiu; S Y Woo; J Ater; J Connelly; J M Bruner; M H Maor; J van Eys; M J Oswald; R Shallenberger
Journal:  J Neurooncol       Date:  1992-07       Impact factor: 4.130
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.